Loading…
Lobbying Spend
—
Filings
14
Firms Hired
1
Active Period
2023–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2024 · fourth_quarter · Firm: DLA PIPER LLP (US)
Legislative and regulatory proposals and policies regarding medical device innovation. H.R. 2369, Verifying Accurate, Leading-edge IVCT Development (VALID) Act of 2023. H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. S. 4638, National Defense Authorization Act for FY2025, provisions regarding medical device innovation.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1691
Legislative and regulatory proposals and policies regarding medical device innovation. H.R. 2369, Verifying Accurate, Leading-edge IVCT Development (VALID) Act of 2023. H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. S. 4638, National Defense Authorization Act for FY2025, provisions regarding medical device innovation.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2369
National Defense Authorization Act for Fiscal Year 2025
2024 · fourth_quarter · Firm: DLA PIPER LLP (US)
Legislative and regulatory proposals and policies regarding medical device innovation. H.R. 2369, Verifying Accurate, Leading-edge IVCT Development (VALID) Act of 2023. H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. S. 4638, National Defense Authorization Act for FY2025, provisions regarding medical device innovation.
Client expense: — · Firm income: $60,000
Matched citations: S. 4638
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2024 · third_quarter · Firm: DLA PIPER LLP (US)
Legislative and regulatory proposals and policies regarding medical device innovation. H.R. 2369, Verifying Accurate, Leading-edge IVCT Development (VALID) Act of 2023. H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1691
Legislative and regulatory proposals and policies regarding medical device innovation. H.R. 2369, Verifying Accurate, Leading-edge IVCT Development (VALID) Act of 2023. H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2369
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2024 · second_quarter · Firm: DLA PIPER LLP (US)
Legislative and regulatory proposals and policies regarding medical device innovation. H.R. 2369, Verifying Accurate, Leading-edge IVCT Development (VALID) Act of 2023. H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1691
Legislative and regulatory proposals and policies regarding medical device innovation. H.R. 2369, Verifying Accurate, Leading-edge IVCT Development (VALID) Act of 2023. H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 2369
Legislative and regulatory proposals and policies regarding medical device innovation. H.R. 2369, Verifying Accurate, Leading-edge IVCT Development (VALID) Act of 2023.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 2369
Legislative and regulatory proposals and policies regarding medical device innovation. H.R. 2369, Verifying Accurate, Leading-edge IVCT Development (VALID) Act of 2023.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2369
Source: Senate LDA